
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.
This has not done well. There are a lot of headwinds in terms of energy loans in their energy bonds. Interest rates not going up is not good for lifecos. It’s a cheap stock. Longer-term, she likes their positioning in Asia, and about a 3rd of their revenues are from there. This is one you might be open to pick at and build a position in. Pretty cheap now.
This continues to struggle with very, very low interest rates, and he expects we are going to have low interest rates for a very long period of time. CRM2, the new regulatory environment, is potentially going to put pressure on mutual fund fees. Pricing on their insurance products is under pressure. Expanding into Asian market places, which is a slow, long slog, and not without its risks. At this price you can own it, but it would be a Sell at $18-$19.
Getting beaten up because of the yield curve collapsing, certainly negative in certain countries around the world, and collapsing in the US, with the 10 year touching 1.37, which is incredibly bad. The Government of Canada 10 year is going to go to at least 1%, which will drag this company down with it. He is Short this.
They will benefit when interest rates go up, but it will be 25 basis points at a time. Apart from the US the rest of the world has been taking interest rates down, though. You need to see global interest rates going up. MFCT-T rates in the bottom third in his ranking. He does not see it forming a base, but he is watching it.
Financials do not rate high on a Buy list in these markets. Has pretty much been Short financials since starting his fund 18 months ago. Insurance companies in particular are in a tough bind. With these low rates, putting premiums to work and earning a decent return without a lot of risk, is very tough. This doesn’t have much European business. Asian and wealth management businesses have been great, but offsetting those 2, they have had some issues with energy debt. The good thing is that it is really cheap. If you take an 18-36 month view, you can be okay.
It is hard for him to get excited about this company. Just when it seems that they are out of the woods, something else happens. The issue for life insurance is the weak Cdn$, low interest rates and that the stock market hasn’t taken off. Trading at 0.9X BV, which would probably be of interest to a deep value investor.
Switch to something better? If you own, stick with it for the time being. Shares are still moving sideways, but starting to inch up. It is still technically below the 200 day moving average, which is not a great long-term signal, but since Feb-April, it is trying to move higher, and he is seeing higher highs and higher lows. A cheap stock at 10X earnings. Dividend yield of 3.95%.
In terms of life insurers, this is arguably one of the best. Under the new CEO, they have separated into 2 focuses, their core business and their investment side. With lifecos, low rates are very detrimental to them and volatility in the stock market is not good. With a company like this, they really need to focus on the core business. A good place to be and a good company.
He owns this because of earnings, valuation, the global diversification, growth, etc. However, it has underperformed. The market concept is that life insurance companies benefit more in a higher or rising interest rate environment. Janet Yellin and Central bankers globally have taken any chance of US rate increases down dramatically. The stock is fine. You go through these hiccups. Thinks it is a better play today than Canadian bank stocks.
Got quite constructive on this after they reported that energy was making up a bigger part of their portfolio and they were seeing some write-downs and things that were impacting their overall Book. This means they have to reserve more which is good for their capital measures or for their ROE. He saw it as a buying opportunity. Relatively undervalued and is a strong dividend paying stock that will continue to grow its dividend as we come out of this cyclical low in energy.
4.2% dividend. They are really about wealth management. They began as an insurance company. His favourite is SLF-T, but that does not mean you sell your MFC-T. It should continue to do well by virtue of the market doing well, however he thinks you may do a little better in SLF-T.